Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-06-007151
Filing Date
2006-02-21
Accepted
2006-02-21 16:08:57
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v035705_10k.htm 10-K 2244812
2 ex10-44.htm EX-10.44A 42284
3 ex10-116.htm EX-10.116 23187
4 ex10-148.htm EX-10.148 25652
5 v035705_ex21.htm EX-21 3521
6 v035705_ex23-1.htm EX-23.1 3732
7 v035705_ex23-2.htm EX-23.2 5602
8 v035705_ex31-1.htm EX-31.1 16496
9 v035705_ex31-2.htm EX-31.2 16384
10 v035705_ex32-1.htm EX-32.1 7326
11 v035705_ex32-2.htm EX-32.2 7341
  Complete submission text file 0001144204-06-007151.txt   2397859
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 06633094
SIC: 2834 Pharmaceutical Preparations